135 related articles for article (PubMed ID: 25779949)
1. A New and Validated Clinical Prognostic Model (EPI) for Enteropathy-Associated T-cell Lymphoma.
de Baaij LR; Berkhof J; van de Water JM; Sieniawski MK; Radersma M; Verbeek WH; Visser OJ; Oudejans JJ; Meijer CJ; Mulder CJ; Lennard AL; Cillessen SA
Clin Cancer Res; 2015 Jul; 21(13):3013-9. PubMed ID: 25779949
[TBL] [Abstract][Full Text] [Related]
2. Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project.
Delabie J; Holte H; Vose JM; Ullrich F; Jaffe ES; Savage KJ; Connors JM; Rimsza L; Harris NL; Müller-Hermelink K; Rüdiger T; Coiffier B; Gascoyne RD; Berger F; Tobinai K; Au WY; Liang R; Montserrat E; Hochberg EP; Pileri S; Federico M; Nathwani B; Armitage JO; Weisenburger DD
Blood; 2011 Jul; 118(1):148-55. PubMed ID: 21566094
[TBL] [Abstract][Full Text] [Related]
3. Validation of the international prognostic index in working formulation group A low-grade non-Hodgkin's lymphoma: retrospective analysis of 137 patients from the Gruppo Italiano per lo Studio dei Linfomi registry.
Stelitano C; Baldini L; Pieresca C; Callea V; Angrilli F; Clò V; Partesotti G; Merli F; Cavanna L; Morabito F; Federico M; Brugiatelli M; Silingardi V
Haematologica; 2000 Feb; 85(2):154-9. PubMed ID: 10681722
[TBL] [Abstract][Full Text] [Related]
4. Enteropathy-Associated T cell Lymphoma.
Al Somali Z; Hamadani M; Kharfan-Dabaja M; Sureda A; El Fakih R; Aljurf M
Curr Hematol Malig Rep; 2021 Apr; 16(2):140-147. PubMed ID: 34009525
[TBL] [Abstract][Full Text] [Related]
5. The International Prognostic Index can be used as a guide to treatment decisions regarding patients with human immunodeficiency virus-related systemic non-Hodgkin lymphoma.
Rossi G; Donisi A; Casari S; Re A; Cadeo G; Carosi G
Cancer; 1999 Dec; 86(11):2391-7. PubMed ID: 10590382
[TBL] [Abstract][Full Text] [Related]
6. Type II enteropathy-associated T-cell lymphoma: a multicenter analysis from the Asia Lymphoma Study Group.
Tse E; Gill H; Loong F; Kim SJ; Ng SB; Tang T; Ko YH; Chng WJ; Lim ST; Kim WS; Kwong YL
Am J Hematol; 2012 Jul; 87(7):663-8. PubMed ID: 22641357
[TBL] [Abstract][Full Text] [Related]
7. [Study of prognostic related factors of elderly patients with T/NK cell lymphoma].
Wang Y; Qian Y; Wu LL; Zhao BB; Xu PP; Zhao WL; Wang L
Zhonghua Xue Ye Xue Za Zhi; 2013 Jan; 34(1):12-5. PubMed ID: 23597457
[TBL] [Abstract][Full Text] [Related]
8. Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study.
Lee J; Suh C; Park YH; Ko YH; Bang SM; Lee JH; Lee DH; Huh J; Oh SY; Kwon HC; Kim HJ; Lee SI; Kim JH; Park J; Oh SJ; Kim K; Jung C; Park K; Kim WS
J Clin Oncol; 2006 Feb; 24(4):612-8. PubMed ID: 16380410
[TBL] [Abstract][Full Text] [Related]
9. Autologous stem cell transplantation for enteropathy-associated T-cell lymphoma: a retrospective study by the EBMT.
Jantunen E; Boumendil A; Finel H; Luan JJ; Johnson P; Rambaldi A; Haynes A; Duchosal MA; Bethge W; Biron P; Carlson K; Craddock C; Rudin C; Finke J; Salles G; Kroschinsky F; Sureda A; Dreger P;
Blood; 2013 Mar; 121(13):2529-32. PubMed ID: 23361910
[TBL] [Abstract][Full Text] [Related]
10. Type II enteropathy-associated T-cell lymphoma: a distinct aggressive lymphoma with frequent γδ T-cell receptor expression.
Chan JK; Chan AC; Cheuk W; Wan SK; Lee WK; Lui YH; Chan WK
Am J Surg Pathol; 2011 Oct; 35(10):1557-69. PubMed ID: 21921780
[TBL] [Abstract][Full Text] [Related]
11. Enteropathy-associated T-cell lymphoma.
Ferreri AJ; Zinzani PL; Govi S; Pileri SA
Crit Rev Oncol Hematol; 2011 Jul; 79(1):84-90. PubMed ID: 20655757
[TBL] [Abstract][Full Text] [Related]
12. Surgery in (pre)malignant celiac disease.
van de Water JM; Nijeboer P; de Baaij LR; Zegers J; Bouma G; Visser OJ; van der Peet DL; Mulder CJ; Meijerink WJ
World J Gastroenterol; 2015 Nov; 21(43):12403-9. PubMed ID: 26604647
[TBL] [Abstract][Full Text] [Related]
13. Second line chemotherapy in patients with enteropathy-associated T cell lymphoma: a retrospective single center analysis.
Raderer M; Troch M; Kiesewetter B; Püspök A; Jaeger U; Hoffmann M; Chott A
Ann Hematol; 2012 Jan; 91(1):57-61. PubMed ID: 21520002
[TBL] [Abstract][Full Text] [Related]
14. The International Prognostic Index assessed at relapse predicts outcomes of autologous transplantation for diffuse large-cell non-Hodgkin's lymphoma in second complete or partial remission.
Lerner RE; Thomas W; Defor TE; Weisdorf DJ; Burns LJ
Biol Blood Marrow Transplant; 2007 Apr; 13(4):486-92. PubMed ID: 17382255
[TBL] [Abstract][Full Text] [Related]
15. Enteropathy-associated T-cell lymphoma: improving treatment strategies.
Nijeboer P; Malamut G; Mulder CJ; Cerf-Bensussan N; Sibon D; Bouma G; Cellier C; Hermine O; Visser O
Dig Dis; 2015; 33(2):231-235. PubMed ID: 25925928
[TBL] [Abstract][Full Text] [Related]
16. Patients with enteropathy-associated T-cell lymphoma in the United States from 2000 to 2018: SEER data-base analysis.
Awad AK; Awan RU; Awad AK; Nabeel A; Dar S; Abegunde AT
Cancer Treat Res Commun; 2023; 36():100745. PubMed ID: 37499419
[TBL] [Abstract][Full Text] [Related]
17. Retrospective analysis of 23 cases with peripheral T-cell lymphoma, unspecified: clinical characteristics and outcome.
Zaja F; Russo D; Silvestri F; Fanin R; Damiani D; Infanti L; Salmaso F; Mariuzzi L; Di Loreto C; Baccarani M
Haematologica; 1997; 82(2):171-7. PubMed ID: 9175321
[TBL] [Abstract][Full Text] [Related]
18. Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience.
Al-Toma A; Verbeek WH; Hadithi M; von Blomberg BM; Mulder CJ
Gut; 2007 Oct; 56(10):1373-8. PubMed ID: 17470479
[TBL] [Abstract][Full Text] [Related]
19. Type II EATL (epitheliotropic intestinal T-cell lymphoma): a neoplasm of intra-epithelial T-cells with predominant CD8αα phenotype.
Tan SY; Chuang SS; Tang T; Tan L; Ko YH; Chuah KL; Ng SB; Chng WJ; Gatter K; Loong F; Liu YH; Hosking P; Cheah PL; Teh BT; Tay K; Koh M; Lim ST
Leukemia; 2013 Aug; 27(8):1688-96. PubMed ID: 23399895
[TBL] [Abstract][Full Text] [Related]
20. Prognostic superiority of the National Comprehensive Cancer Network International Prognostic Index over pretreatment whole-body volumetric-metabolic FDG-PET/CT metrics in diffuse large B-cell lymphoma.
Adams HJ; de Klerk JM; Fijnheer R; Heggelman BG; Dubois SV; Nievelstein RA; Kwee TC
Eur J Haematol; 2015 Jun; 94(6):532-9. PubMed ID: 25311082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
